|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02877 SHINEWAY PHARM
Nominal 
8.410 +0.080 (+0.960%) | 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | 2020/06 RMB(K¥) | |
| Turnover | 2,086,695 | -13.007% | 2,398,680 | 1,815,194 | 1,554,097 | 1,190,112 |
| Cost of Sales | (514,511) | -13.487% | (594,723) | (490,380) | (407,067) | (313,747) |
| Gross Profit | 1,572,184 | -12.848% | 1,803,957 | 1,324,814 | 1,147,030 | 876,365 |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | 2020/06 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (4,286) | -31.270% | (6,236) | (1,443) | (525) | (3,487) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 862,083 | 28.422% | 671,288 | 411,408 | 380,422 | 301,809 | |
| Taxation | (235,604) | 31.020% | (179,823) | (80,285) | (71,966) | (48,088) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 626,479 | 27.472% | 491,465 | 331,123 | 308,456 | 253,721 | |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | 2020/06 RMB(K¥) | |
| Net Finance Costs / (Income) | (118,321) | -- | 171 | (52,678) | (45,821) | (37,902) |
| Depreciation & Amortisation | 80,678 | -6.300% | 86,102 | 93,868 | 89,331 | 104,094 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/06 | 2022/06 | 2021/06 | 2020/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/06 | 2022/06 | 2021/06 | 2020/06 | |
| EPS (cts) | 83.000 | 27.692% | 65.000 | 44.000 | 41.000 | 33.000 |
| DPS (cts) | 54.000 | -- | 42.000 | 32.000 | 39.000 | 11.000 |
| Dividend Payout Ratio (%) | 65.060% | -- | 64.615% | 72.727% | 95.122% | 33.333% |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 8.871 | -- | 8.029 | 7.345 | 7.192 | 7.057 |
| Remarks: | Real time quote last updated: 15/11/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 626,479 |
| %Change | 27.472% |
| EPS / (LPS) | RMB 0.830 |
| NBV Per Share (¥) | RMB 8.871 |